FOR LABORATORY RESEARCH USE ONLY · NOT FOR HUMAN CONSUMPTION
◀ INDEXGIGARESEARCH
EPITALON molecular structure

NO. 023 · LONGEVITY

EPITALON

Telomerase Activator · Khavinson

REVIEWED BY · GIGACOMPOUNDS RESEARCH DESK·LAST UPDATED · 2026-05-19
LONGEVITY

ALIASES

Epitalon, Epithalon, Epithalamin analog, AEDG

CLASS

Synthetic Khavinson tetrapeptide · pineal-axis research

FORMULA

C₁₄H₂₂N₄O₉

SEQUENCE

Ala-Glu-Asp-Gly

HALF-LIFE

Very short (minutes) plasma; tissue-localized longer

ROUTES

Subcutaneous (Russian research protocol) · Intranasal (some sources)

MECHANISM OF ACTION

Four-amino-acid synthetic peptide (Ala-Glu-Asp-Gly) with telomerase-activating activity in human somatic cells. Developed at the St. Petersburg Institute of Bioregulation and Gerontology. Russian clinical use spans 30+ years; mainstream Western RCT-grade evidence is limited.

EVIDENCE GRADES

Telomerase activation (in vitro)C

Khavinson 2003 reported telomerase upregulation in human peripheral blood lymphocytes; replication outside Khavinson network is limited.

Long-term mortality (observational)D

12-year Russian observational study of 266 patients · not a randomized double-blind design; treat as preliminary.

MECHANISM CATEGORIES

SAFETY

Side effects

  • Very limited Western safety data
  • No serious adverse events reported in Russian literature at standard doses

Drug interactions

  • Largely unstudied in Western literature

Contraindications

  • Active malignancy (theoretical · telomerase activation may interact with cancer biology · NOT validated)

REGULATORY STATUS

FDA · Not FDA-approved. Research-use only in the United States.

WADA · Not currently listed on the WADA Prohibited List.

STORAGE

Lyophilized · -20 °C 24 months

Reconstituted · 2-8 °C, 14-21 days

PEER-REVIEWED EVIDENCE

  • Khavinson VKh. Peptides and Ageing. Neuro Endocrinol Lett 2002. PMID 12624353. link →
  • Khavinson V, et al.. Effects of pineal peptide preparation Epithalamin on free-radical processes in humans and animals. Neuro Endocrinol Lett 2003. PMID 14523389. link →

FAQ · 7 QUESTIONS

What is Epitalon?

Epitalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly, AEDG) developed by Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology in Russia. It is the synthetic analog of the pineal extract epithalamin.

Is Epitalon the same as epithalamin?

Epithalamin is the natural pineal-extract preparation; Epitalon (also called epithalon) is the synthetic tetrapeptide AEDG that captures the active short-peptide component.

Is Epitalon FDA-approved?

No. Epitalon is research-use only in the United States. It is registered as a clinical-research compound within the Russian Federation by the Institute of Bioregulation and Gerontology.

How does Epitalon work?

Proposed mechanisms include telomerase activation in somatic cells (Khavinson 2003, PMID 14523389), modulation of melatonin secretion via pineal gland action, and influence on circadian clock-gene expression. Replication outside the Khavinson network is limited.

Is the evidence base reliable?

Most published research comes from the Khavinson group in Russia and is in Russian-language journals. The 12-year mortality study is observational, not randomized double-blind. Treat the evidence base as preliminary.

What dose is used in research?

Russian-protocol literature uses subcutaneous 5-10 mg/day in 10-20 day cycles, 1-2 times per year. This wiki does not recommend any human dose.

Side effects?

Very limited Western safety data. No serious adverse events reported in Russian literature at standard doses; appropriate caution warranted given the limited Western RCT base.

SIGNATURE MOVES

Telomere CapPOW 80

Rebuild telomere ends. Khavinson 30-year clinical work.

Pineal SurgePOW 130

Russian gerontology classic. Pineal regulation.

SOURCED FROM GIGACOMPOUNDS

Reference compounds documented on this page are available as research-grade material at GigaCompounds · ≥99% purity · per-batch Certificate of Analysis. For laboratory research use only. No human dose is recommended by this wiki.

SOURCE AT GIGACOMPOUNDS ▶WIKI ENTRY ▶

▶ LAST UPDATED · 2026-05-19

© 2026 GigaCompounds LLC · For Laboratory Research Use Only